AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimvay 2 Tablet ER

Prescription Icon
Prescription Required

Marketer

Anevay Pharmaceuticals Pvt. Ltd.

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimvay 2 Tablet ER

Duogest ER tablets are classified as antidiabetic medications, combining two agents to manage type 2 diabetes in adults. This dual-action formulation helps regulate blood glucose. Duogest ER should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial, even with controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose, potentially resulting in kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as recommended by your doctor. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to counteract them with a fast-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption should be limited due to increased hypoglycemia risk. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, or severe liver or kidney disease. Individuals with a history of heart disease should inform their doctor before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose checks are necessary, and your doctor may order blood tests to monitor blood cell counts and liver function.

Uses of Glimvay 2 Tablet ER

Managing Type 2 Diabetes

Major Benefits of Glimvay 2 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimvay 2 Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Glimvay 2 Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimvay 2 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimvay 2 Extended-Release Tablet should be administered with a meal.

How Glimvay 2 Tablet ER works:

Glimvay 2 ER tablets contain a dual-action antidiabetic formulation: glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood sugar levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimvay 2 Tablet ER and alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimvay 2 Tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimvay 2 tablets are contraindicated for breastfeeding mothers. Studies indicate potential infant toxicity associated with this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Glimvay 2 Tablet ER to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Glimvay 2 Tablet ER is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimvay 2 Tablet ER cautiously, potentially requiring dose modification. Consult a physician. Low initial doses are typically prescribed for individuals with mild to moderate liver disease; however, Glimvay 2 Tablet ER is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Glimvay 2 Tablet ER :

Should you forget a Glimvay 2 Tablet ER dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimvay 2 Tablet ER

LabelValue
Potential for Dependence None.
Type of Treatment Medication for diabetes

FAQs on Glimvay 2 Tablet ER

Retain this medication within its original, tightly sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Prevent access by children, pets, and others.
Glimvay 2 Tablet ER use carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed Metformin-associated lactic acidosis (MALA), this rare but potentially harmful side effect is more likely in patients with kidney impairment, the elderly, or those consuming substantial alcohol. Symptoms can manifest as muscle aches or weakness, vertigo, fatigue, cold extremities, dyspnea, nausea, vomiting, abdominal discomfort, or bradycardia. Should these symptoms arise, discontinue Glimvay 2 Tablet ER and seek immediate medical attention.
Glimvay 2 ER tablets contain glimepiride and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This dual-action medication enhances glycemic control when combined with a healthy diet and exercise regimen. Glimepiride stimulates pancreatic insulin secretion, while metformin reduces hepatic glucose production and increases insulin responsiveness. This formulation is unsuitable for managing type 1 diabetes.
Glimvay 2 Tablet ER may cause common adverse reactions including low blood sugar (hypoglycemia), taste disturbances, nausea, abdominal discomfort, diarrhea, and headache. Rare but potentially serious side effects such as lactic acidosis are also possible. Prolonged treatment may result in vitamin B12 deficiency.
Indeed, prolonged Glimvay 2 Tablet ER administration can lead to Vitamin B12 depletion. This medication hinders Vitamin B12 absorption within the gastrointestinal tract. Untreated deficiency may result in anemia, neurological complications, including paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and gait instability. Preventive measures proposed by some studies include annual supplemental Vitamin B12 intake.
Glimvay 2 Tablet ER can indeed induce hypoglycemia, characterized by low blood sugar. Manifestations of this condition may encompass nausea, headache, irritability, increased hunger, sweating, dizziness, tachycardia, and feelings of anxiety or tremor. The risk of hypoglycemia is heightened by missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Consequently, consistent blood glucose monitoring is crucial. Carrying a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice, is recommended.
Combining Glimvay 2 Tablet ER and alcohol is unsafe. This combination can cause dangerously low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimvay 2 Tablet ER
53
MRP 65
18% off